Skip to main content
OpenTrials
Completed

NCT Number: NCT01056250

SILS Cholecystectomy: Cholangiography of the Biliary Tract

Single Incision Laparoscopic Surgery (SILS) can be performed for different standard operations such as appendectomy and cholecystectomy. During laparoscopic cholecystectomy sometimes a cholangiography (marking the biliary tract with contrast agent) is necessary to identify and preserve relevant structures. The investigators want to evaluate feasibility of performing cholangiography during SILS cholecystectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St John of God Hospital

Vienna, State of Vienna, 1180, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cholecystolithiasis

Exclusion criteria

  • acute cholecystitis

Treatment and study plan

SILS cholangiography

Procedure

intraoperative

Other names: LESS, E-NOTES

Primary outcomes

  1. Feasibility of cholangiography during SILS cholecystectomy

    Time frame: at operation

Secondary outcomes

  1. biliary tract injury

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

St John of God Hospital, Vienna

Other

Registry information

Official study title

Performing Cholangiography During SILS Cholecystectomy: is it Feasible?

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Jan 26, 2010
Registry last updated
May 10, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.